Back to Search Start Over

Aberrant B-cell activation and B-cell subpopulations in rheumatoid arthritis: analysis by clinical activity, autoantibody seropositivity, and treatment.

Authors :
Morales-Núñez, José Javier
Muñoz-Valle, José Francisco
García-Chagollán, Mariel
Cerpa-Cruz, Sergio
Martínez-Bonilla, Gloria Esther
Medina-Rosales, Vianey Monserrat
Díaz-Pérez, Saúl Alberto
Nicoletti, Ferdinando
Hernández-Bello, Jorge
Source :
Clinical & Experimental Immunology. Dec2023, Vol. 214 Issue 3, p314-327. 14p.
Publication Year :
2023

Abstract

Few studies analyze the role of B-cell subpopulations in rheumatoid arthritis (RA) pathophysiology. Therefore, this study aimed to analyze the differences in B-cell subpopulations and B-cell activation according to disease activity, RA subtype, and absence of disease-modifying antirheumatic drugs (DMARDs) therapy. These subgroups were compared with control subjects (CS). One hundred and thirty-nine subjects were included, of which 114 were RA patients, and 25 were controls. Patients were divided into 99 with seropositive RA, 6 with seronegative RA, and 9 without DMARDs. The patients with seropositive RA were subclassified based on the DAS28 index. A seven-color multicolor flow cytometry panel was used to identify B-cell immunophenotypes and cell activation markers. There were no changes in total B-cell frequencies between RA patients and controls. However, a lower frequency of memory B cells and pre-plasmablasts was observed in seropositive RA compared to controls (P < 0.0001; P = 0.0043, respectively). In contrast, a higher frequency of mature B cells was observed in RA than in controls (P = 0.0002). Among patients with RA, those with moderate activity had a higher percentage of B cells (P = 0.0021). The CD69+ marker was increased (P < 0.0001) in RA compared to controls, while the CD40+ frequency was decreased in patients (P < 0.0001). Transitional, naïve, and double-negative B-cell subpopulations were higher in seronegative RA than in seropositive (P < 0.01). In conclusion, in seropositive and seronegative RA patients, there are alterations in B-cell activation and B-cell subpopulations, independently of clinical activity and DMARDs therapy. In rheumatoid arthritis, B cells play an important role in the pathophysiology of the disease; at the peripheral level, seropositive arthritis shows an imbalance in memory B cells, pre-plasmablast and mature B cells, while for seronegative arthritis, transitional B cells, naive B cells, and double negative B cells are the ones that have an imbalance Graphical Abstract [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
00099104
Volume :
214
Issue :
3
Database :
Academic Search Index
Journal :
Clinical & Experimental Immunology
Publication Type :
Academic Journal
Accession number :
174783799
Full Text :
https://doi.org/10.1093/cei/uxad076